Monoclonal antibodies which bind to tumor rejection antigen prec

Details Monoclonal antibodies which bind to tumor rejection antigen prec Monoclonal antibodies which bind to tumor rejection antigen prec

1994-02-01

1996-07-30

Budens, Robert C.

Chemistry: molecular biology and microbiology

Spore forming or isolating process

435 696, 435 7021, 4351722, 530350, 5303877, 5303888, 935 15, 4241381, 4241551, 4241741, C12P 2104, C12P 2108, C12N 500, C07K 1600

Patent

active

055411045

ABSTRACT:
The invention relates to monoclonal antibodies which specifically bind to the tumor rejection antigen precursor molecule MAGE-1, hybridomas which produce these monoclonal antibodies, and their use. Also described is a recombinant form of MAGE-1, peptides which are useful as immunogens, and immunogenic compositions containing the peptides and an adjuvant.

REFERENCES:
patent: 5342774 (1994-08-01), Boon et al.

Affiliated with

Also associated with

Rating

Monoclonal antibodies which bind to tumor rejection antigen prec does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibodies which bind to tumor rejection antigen prec, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies which bind to tumor rejection antigen prec will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1657929